Percutaneous transthoracic core needle biopsy has been advocated as a highly accurate technique for the diagnosis of anterior mediastinal masses. A patient is described with a large anterior mediastinal mass in whom the diagnosis of mediastinal carcinoid tumour was made by transthoracic core needle biopsy. At definitive surgical resection the tumour proved to be a B cell lymphoma. This case illustrates one ofthe important limitations ofneedle biopsy with its potential for sampling error.
The development of the minimally invasive technique of percutaneous needle biopsy has Figure 1 Representative image from a contrast enhanced computed tomographic scan of the chest taken at a level 2 cm inferior to the carina. A 10 cm x 10 cm x 8 cm homogenous mass can be seen in the anterior mediastinum that abuts, and possibly invades, the sternum and chest wall, displacing the great vessels and heart to the left. A moderate sized right pleural effusion is also present.
proved to be invaluable in obtaining diagnostic tissue from most body compartments. The use ofthis technique has risen dramatically with the evolution of sophisticated imaging techniques especially computed tomographic (CT) scanning. The most recent anatomical area to be targeted for needle biopsy is the mediastinum. The literature is replete with multiple series advocating not only fine needle aspiration, but now core needle biopsy of lesions in this body compartment including the anterior mediastinum with its diverse population of potential tumours.'3 The following case report illustrates the diagnostic fallibility of core needle biopsies, particularly of histologically similar, hypercellular anterior mediastinal neoplasms, that influence subsequent definitive therapy.
Case report A 37 year old white woman presented with a six week history of a tight full sensation in her chest accompanied by right anterolateral chest pain which was worsened by alcohol ingestion. During the previous two weeks she had noted some dyspnoea on exertion, a non-productive cough, and a 3 kg weight loss. She also reported some diarrhoea for several weeks but this had resolved. She smoked one pack of cigarettes per day. She had no history of flushing, fever, night sweats, pruritus or other constitutional symptoms, or any other significant medical problems. She had a strong family history of a variety of cancers in three uncles and a grandmother. Her physical examination was normal.
A chest radiograph demonstrated a large anterior and middle mediastinal mass. CT scans of the chest and abdomen (fig 1) As with any diagnostic procedure, there are definite advantages as well as limitations to transthoracic needle biopsies of mediastinal masses, especially in the anterior compartment. Ferguson et al in a series of patients with anterior mediastinal masses found that, based on histological findings, non-resectional therapy was the most appropriate treatment in 61% of cases.8 A selective approach to diagnosis and treatment is therefore warranted based on clinical suspicions and the results of imaging studies. For example, in a patient with a clinically non-invasive anterior mediastinal mass, primary surgical excision without prior biopsy is recommended. In fact, incisional (needle or scalpel) biopsy of a clinically localised (stage I or II) thymoma is contraindicated since violation of the tumour capsule may jeopardise the chances for the excellent surgical result expected with this lesion.7 Nagasaka et al recently reported a case of needle tract implantation of thymoma after transthoracic needle biopsy which, of necessity, violated the tumour capsule. hibiting nucleic acid and protein synthesis. Pulmonary toxicity has been described after the administration of 1 2-1. 5g/m2 of the drug.' BCNU is not known to have a preference for any particular zone of the lung, nor are preexisting insults known to predispose to this side effect. Pneumonitis and fibrosis after lung irradiation are well described.2 Pneumonitis usually occurs 6-12 weeks after the first fraction and often progresses to pulmonary fibrosis by two years. Lymphocyte activity may be seen in areas of lung outside the field of radiation, but most radiographic change is within the treatment zone.
A combination of these two agents would be expected to increase the risk of serious lung damage and we present a case of such toxicity.
Case report A 51 year old woman developed a subcutaneous mass on the right chest wall which was diagnosed as a localised high grade non-Hodgkin's lymphoma from a right axillary lymph node biopsy.
She was treated over the course of the next three months with three cycles of combination chemotherapy (CHOP: cyclophosphamide (total 4-6 g), adriamycin, vincristine, and prednisolone) with limited response and eventual disease progression. A further course ofchemotherapy was tried at approximately nine months after presentation (ifosphamide (total 6-9 g), methotrexate (total 45 mg), and etoposide). 
